Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Projected to Reach $8.12 Billion by 2029 at a CAGR of 3.17%
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Through 2034?
The market size for the lateral flow immunoassay (lfia) based rapid test has seen a sharp decrease in recent times. Predictions indicate a fall from $8.03 billion in 2024 to $7.17 billion in 2025, showcasing a compound annual growth rate (CAGR) of -10.7%. Factors contributing to this downward trend in the historic period include limited sensitivity and specificity, complications related to multiplexing, cross-reactivity problems, challenges with storage and shelf-life, and limited quantitative capability.
The market size for rapid tests based on the lateral flow immunoassay (LFIA) is forecasted to experience steady growth in the upcoming years, reaching a worth of $8.12 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 3.2%. Factors contributing to the decline during the forecast period include global supply chain disruptions, regulatory hurdles, heightening competition, the rise of alternative technologies, and the incorporation of digital health platforms. The projected period is expected to observe trends like the development of advanced technologies for multiple or regular LFIA based rapid tests as well as the storage and communication of results. Emphasis will be on partnerships and collaborations, creating home test kits, investing in artificial intelligence-based disease screening and detection tests, and manufacturing low-cost test kits to ensure affordable access for patients.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3293&type=smp
What are the Fundamental Drivers and Innovations Shaping the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market?
The challenge of maintaining quality assurance continues to impede the progress of the lateral flow immunoassay (LFIA) based rapid test market. Elevated operational expenditures, comprising of salary and technological venture costs, are squeezing profit margins across numerous law firms. This issue was highlighted by an evaluation by PLOS, a non-profit organization in the US in June 2023, indicating that LFIA products in the market do not consistently uphold stringent reliability and specificity standards. A retrospective review of four LFIA tests revealed considerable variance in their diagnostic capacities, with shockingly low accuracy results, some as low as 47% for IgG detection.
How Is the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmented?
The lateral flow immunoassay (lfia) based rapid testmarket covered in this report is segmented –
1) By Technique: Competitive Assay, Sandwich Assay, Multiplex Detection Assay
2) By Application: Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing, Other Applications
3) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End Users
Subsegments:
1) By Competitive Assay: Direct Competitive Assays, Indirect Competitive Assays
2) By Sandwich Assay: Single-step Sandwich Assays, Two-step Sandwich Assays
3) By Multiplex Detection Assay: Multi-analyte Assays, Simultaneous Detection Of Various Targets
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=3293&type=smp
Which Regions Are Driving the Next Phase of the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Growth?
North America was the largest region in the lateral flow immunoassay (LFIA) based rapid test market in 2024. Asia-Pacific was the second largest region in the global lateral flow immunoassay (LFIA) based rapid test market. The regions covered in the lateral flow immunoassay (LFIA) based rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Key Trends Are Shaping the Future of the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market?
Big players in the lateral flow immunoassay (LFIA) based rapid test market are concentrating on areas like qPCR technology to improve the trustworthiness and exactitude of their tests, accelerate detection rate, and broaden the scope of detectable pathogens or biomarkers. This is aimed at providing more dependable and precise diagnostic tools for a variety of health-related utilization. QPCR (quantitative polymerase chain reaction) technology is a method in molecular biology for amplifying and quantifying DNA or RNA sequences in real time, allowing for accurate measurement of gene expression or specific pathogen detection in diverse samples. For example, in November 2023, Switzerland’s pharmaceutical firm, F. Hoffmann-La Roche AG, introduced the LightCycler PRO System which is an enhancement of Roche’s line of qPCR systems, employing the finest technology for unparalleled quality, precision, and reliability. These attributes are essential for precise patient diagnosis and beneficial clinical decision-making.
View the full report here:
How Is the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Defined and What Are Its Core Parameters?
Lateral Flow Immunoassay (LFIA) based rapid test is a simple technology-based diagnostic device that is used to determine the presence of a target such as pathogens or biomarkers in samples collected from the human body. These samples may include urine, saliva, blood, sweat and other fluids.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3293
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model